Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Beijing Da Xue Xue Bao Yi Xue Ban ; 45(3): 469-73, 2013 Jun 18.
Article in Chinese | MEDLINE | ID: mdl-23774930

ABSTRACT

OBJECTIVE: To build a mathematical model to simulate the drug distribution accompanying with diffusion, distribution and clearance in the brain extracellular space (ECS). METHODS: Magnetic resonance imaging (MRI) technology was used to monitor changes in the signal-intensity-related tracer gadolinium-diethylene triamine pentaacetic acidm(Gd-DTPA), as an external drug which was injected into the rat brain, and then the mathematical model was built by using the data to establish the diffusion, distribution and clearance process of Gd-DTPA in the brain ECS. The model equation was resolved by Laplace transform. In the sphere coordinates, the linear regressive model was adopted to obtain the estimation method of diffusion coefficient, clearance rate of drugs distribution in the brain ECS. RESULTS: The diffusion coefficient D and the clearance rate k were obtained as (2.73±0.364)×10(-4) mm(2)/s and (1.40±0.206)×10(-5) /s, respectively. CONCLUSION: The proposed method can accurately reflect the isotropic drug distribution in the brain ECS, and can serve as the foundation to further solve problems about the orthotropic distribution in the brain ECS.


Subject(s)
Brain , Extracellular Space , Gadolinium DTPA/pharmacokinetics , Magnetic Resonance Imaging , Animals , Diffusion , Linear Models , Rats
2.
J Ethnopharmacol ; 127(3): 702-8, 2010 Feb 17.
Article in English | MEDLINE | ID: mdl-19969061

ABSTRACT

AIM OF THE STUDY: Gekko swinhonis Guenther has been used as an anti-cancer drug in traditional Chinese medicine for hundreds of years. Here we investigated the structural characterization and anti-cancer effects of sulfated polysaccharide-protein complex (GSPP) isolated from Gekko swinhonis Guenther. MATERIALS AND METHODS: The structure of GSPP was characterized by high performance liquid chromatography, gas chromatography, gas chromatography-mass spectrometry, beta-elimination reaction, and NMR spectroscopy. SMMC-7721 cells were used to assess the influence of GSPP on hepatocellular carcinoma. Cell proliferation and survival was determined by trypan blue exclusion assay. Cell migration was performed by wound-healing and transwell assay. The secretion of IL-8 was detected by an enzyme-linked immunosorbent assay kit. Flow cytometry was used to analyze intracellular calcium concentration, as well as cell cycle distribution and apoptosis. Confocal microscopy was used to assess the localization and configuration of actin filaments. RESULTS: GSPP was chemically characterized as a sulfated polysaccharide-protein complex with O-glycopeptide linkages. Our results showed that GSPP inhibited the proliferation of SMMC-7721 cells and blocked cells in the S phase. No direct toxicity against cells was observed. Furthermore, GSPP inhibited the migration of SMMC-7721 cells with the reduction of intracellular calcium. Actin filaments were polymerized and accumulated in the cytoplasm of the treated cells, whereas the secretion of IL-8 was not significantly changed after GSPP exposure. CONCLUSION: We describe an identified sulfated polysaccharide-protein complex, and demonstrate its direct effect on hepatocellular carcinoma cell migration via calcium-mediated regulation of the actin cytoskeleton reorganization.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Hepatocellular/drug therapy , Cell Proliferation/drug effects , Glycoproteins/therapeutic use , Liver Neoplasms/drug therapy , Lizards , Polysaccharides/therapeutic use , Actin Cytoskeleton/metabolism , Actins/metabolism , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/isolation & purification , Antineoplastic Agents/pharmacology , Calcium/metabolism , Carcinoma, Hepatocellular/secondary , Cell Line, Tumor , Glycoproteins/chemistry , Glycoproteins/pharmacology , Interleukin-8/metabolism , Liver Neoplasms/metabolism , Liver Neoplasms/secondary , Medicine, Chinese Traditional , Neoplasm Invasiveness , Organotherapy , Polysaccharides/pharmacology , S Phase/drug effects
3.
Biorheology ; 45(5): 587-98, 2008.
Article in English | MEDLINE | ID: mdl-19065007

ABSTRACT

There is evidence that hyperlipidemia can induce hemorheological and microcirculatory disturbances. Myakuryu, a Chinese traditional medicine is efficacious in promoting lipid metabolism and protecting oxidative stress, but whether this drug can ameliorate rheologic disturbances caused by hyperlipidemia is still unknown. The present study was conducted to investigate the effects of myakuryu on hemorheological and microcirculatory disturbances induced by hyperlipidemia. Wistar rats were divided into a group on control diet (n=8) and a group on high-fat diet (HFD, n=44). Eight weeks later, plasma triglyceride (TG) and total cholesterol (TC) were determined. Sixteen animals with the highest levels of hyperlipidemia from the HFD group were randomly divided into two sub-groups: the untreated hyperlipidemia group (n=8) and the group treated with myakuryu (n=8). At the end of the sixteenth week, rheological and microcirculatory parameters were measured. Chemical analysis showed that myakuryu treatment caused significant reductions of plasma TG and TC levels (P<0.01), and the cholesterol/phospholipid ratio in the erythrocyte membrane (P<0.05). Rheological and microcirculatory measurements showed that myakuryu treatment led to a significant decrease in the erythrocyte aggregation index, plasma viscosity and blood viscosity at shear rates of 50, 100 and 150 s(-1) and in adherent leukocytes in mesenteric venules. There was a significant increase in erythrocyte deformation, electrophoretic mobility, membrane fluidity and F-actin content in the erythrocyte membrane as well as in red cell velocity in mesenteric venules. Our findings suggest that myakuryu treatment can improve blood flow and reduce adherent leukocytes in the venules of rats fed with HFD by ameliorating blood viscosity, erythrocyte deformability and aggregation, and other hemorheological characteristics.


Subject(s)
Hemorheology/drug effects , Hyperlipidemias/blood , Phytotherapy/methods , Plant Preparations/pharmacology , Actins/blood , Animals , Blood Flow Velocity/drug effects , Blood Viscosity/drug effects , Body Weight , Cell Adhesion/drug effects , Dietary Fats/administration & dosage , Drug Evaluation, Preclinical/methods , Erythrocyte Aggregation/drug effects , Erythrocyte Membrane/metabolism , Hyperlipidemias/drug therapy , Hyperlipidemias/physiopathology , Leukocytes/drug effects , Lipids/blood , Membrane Fluidity/drug effects , Mesenteric Veins/drug effects , Mesenteric Veins/physiopathology , Microcirculation/drug effects , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Plant Preparations/therapeutic use , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...